Bausch + Lomb launched a preservative-free form of Lumify redness-reducing eye drops in the U.S., according to a press ...

The FDA granted approval to mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

Adolescents with mental health issues who were admitted to a pediatric inpatient psychiatry unit experienced significant ...

Adults with obesity using a GLP-1 have a similar risk for obesity-related cancers as those who undergo bariatric surgery, ...

Long-term outcomes after CT or invasive coronary angiography to diagnose CAD were similar, with comparable improvement in ...

An FDA committee on Thursday recommended that COVID-19 vaccines for the 2025-2026 respiratory virus season — which, for the ...

Drug and alcohol references in popular music not only correlate with use, but they also provide opportunities for engaging ...

In ALS, a neurodegenerative condition that leads to loss of muscle control and executive function, there is a need for ...

The FDA approved Yutrepia inhalation powder for the treatment of pulmonary arterial hypertension and pulmonary hypertension ...

The FDA cleared an investigational new drug application for a phase 2 trial of GRF312 ophthalmic solution, an immunoglobulin ...

Children and young adults in states with high Medicaid disenrollment rates were more likely to experience disruptions in ...

A hand hygiene intervention, which encouraged patients and visitors to the participating units to perform audits of health ...